Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
April 9, 2008

Caliper Enhances Cell-Line Offerings by Incorporating Horizon Discovery’s Isogenic Technology

  • Caliper Life Sciences has gained access to Horizon Discovery isogenic cell lines and will incorporate them into its  existing oncology cell-proliferation panel.

    The agreement will expand Caliper Discovery Alliances and Services' (CDAS) oncology cell line and screening capabilities for testing single drugs and combination therapies. As a result, CDAS will now offer genetically defined and isogenic human cancer cell lines that allow researchers to better identify and characterize personalized drugs targeted at a specific subset of patients.